A new technique for generating pathogenic barcodes in breast cancer susceptibility analysis

Journal of Theoretical Biology

Volumn 366, Issue , 2015, Pages 84-90

  Li, Xiong ^a   Liao, Bo ^a   Chen, Haowen ^a  

^a HUNAN UNIVERSITY   (China)

Author keywords

Breast cancer; Entropy; Epistasis; Odds ratio; Single nucleotide polymorphism

Indexed keywords

ALGORITHM; ARTIFICIAL INTELLIGENCE; CANCER; ENTROPY; EPISTASIS; PATHOGEN; POLYMORPHISM;

ANALYTIC METHOD; ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; CLINICAL CLASSIFICATION; DATA PROCESSING; ENTROPY; GENOTYPE; INTERMETHOD COMPARISON; MATHEMATICAL GENETICS; MAXIMUM DISSIMILARITY MINIMUM ENTROPY; PATHOGENIC BARCODE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; ALGORITHM; BREAST TUMOR; FEMALE; GENETIC DATABASE; GENETIC PREDISPOSITION; GENETICS; HUMAN; ODDS RATIO; PATHOLOGY; RISK; RISK FACTOR;

ALGORITHMS; BREAST NEOPLASMS; DATABASES, GENETIC; ENTROPY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84916942203     PISSN: 00225193     EISSN: 10958541     Source Type: Journal    
DOI: 10.1016/j.jtbi.2014.11.005     Document Type: Article

References (27)

1. Chakravarti A., Clark A.G., Mootha V.K. Distilling pathophysiology from complex disease genetics. Cell 2013, 155(1):21-26.
2. Chang H.W., Yang C.H., Ho C.H., et al. Generating SNP barcode to evaluate SNP-SNP interaction of disease by particle swarm optimization. Comput. Biol. Chem. 2009, 33(1):114-119.
3. Chen W., Feng P.M., Deng E.Z. iTIS-PseTNC: a sequence-based predictor for identifying translation initiation site in human genes using pseudo trinucleotide composition. Anal. Biochem. 2014, 462:76-83.
4. Chen W., Feng P.M., Lin H. iRSpot-PseDNC: identify recombination spots with pseudo dinucleotide composition. Nucleic Acids Res. 2013, 41(6):e69.
5. Chou K.C. Some remarks on predicting multi-label attributes in molecular biosystems. Mol. Biosyst. 2013, 9(6):1092-1100.
6. Chou K.C. Some remarks on protein attribute prediction and pseudo amino acid composition. J. Theor. Biol. 2011, 273(1):236-247.
7. Chou K.C., Shen H.B. Review: recent advances in developing web-servers for predicting protein attributes. Nat. Sci. 2009, 1(2):63-92.
8. Chuang L.Y., Chang H.W., Lin M.C., et al. Improved branch and bound algorithm for detecting SNP-SNP interactions in breast cancer. journal of clinical bioinformatics 2013, 3(4):1-10.
9. Daniels R., Volkman S.K., Milner D.A., et al. A general SNP-based molecular barcode for Plasmodium falciparum identification and tracking. Malar. J. 2008, 7(1):223.
10. Flintoft L. Complex disease: a SNP for disease prognosis. Nat. Rev. Genet. 2013, 14(11):746. (-746).
11. Gabriel C.A., Mitra N., DeMichele A., et al. Association of progesterone receptor gene (PGR) variants and breast cancer risk in African American women. Breast Cancer Res. Treat. 2013, 1-11.
12. Hu T., Chen Y., Kiralis J.W., et al. An information-gain approach to detecting three-way epistatic interactions in genetic association studies. J.Am. Med. Inf. Assoc. 2013, 20(4):630-636.
13. Liu B., Zhang D., Xu R., et al. Combining evolutionary information extracted from frequency profiles with sequence-based kernels for protein remote homology detection. Bioinformatics 2014, 30(4):472-479.
14. Mooney M., Wilmot B., McWeeney S. The GA and the GWAS: using genetic algorithms to search for multilocus associations. IEEE/ACM Trans. Comput. Biol. Bioinf. 2012, 9(3):899-910.
15. Pharoah P.D.P., Tyrer J., Dunning A.M., et al. Association between common variation in 120 candidate genes and breast cancer risk. PLoS Genet. 2007, 3(3):e42.
16. Reich D.E., Lander E.S. On the allelic spectrum of human disease. Trends Genet 2001, 17(9):502-510.
17. Robinson D.R., Wu Y.M., Vats P., et al. Activating ESR1 mutations in hormone-resistant metastatic breast cancer. Nat. Genet. 2013, 45(12):1446-1451.
18. Toy W., Shen Y., Won H., et al. ESR1 ligand-binding domain mutations in hormone-resistant breast cancer. Nat. Genet. 2013, 45(12):1439-1445.
19. Udler M.S., Azzato E.M., Healey C.S., et al. Common germline polymorphisms in COMT, CYP19A1, ESR1, PGR, SULT1E1 and STS and survival after a diagnosis of breast cancer. Int. J. Cancer 2009, 125(11):2687-2696.
20. Wu Z.C., Xiao X. iLoc-Hum: using accumulation-label scale to predict subcellular locations of human proteins with both single and multiple sites. Mol. Biosyst. 2012, 8(2):639-641.
21. Xiao X., Wang P., Lin W.Z. iAMP-2L: a two-level multi-label classifier for identifying antimicrobial peptides and their functional types. Anal. Biochem. 2013, 436(2):168-177.
22. Xu Y., Ding J., Wu L.Y. iSNO-PseAAC: predict cysteine S-nitrosylation sites in proteins by incorporating position specific amino acid propensity into pseudo amino acid composition. PLoS One 2013, 8:e55844.
23. Xu Y., Wen X., Wen L.S., et al. iNitro-Tyr: prediction of nitrotyrosine sites in proteins with general pseudo amino acid composition. PLoS One 2014, 9:e105018.
24. Yang C.H., Lin Y.D., Chuang L.Y., et al. Evaluation of breast cancer susceptibility using improved genetic algorithms to generate genotype SNP barcodes. IEEE/ACM Trans. Comput. Biol. Bioinf. 2013, 10(2):361-371.
25. Yang J., Ferreira T., Morris A.P., et al. Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits. Nat. Genet. 2012, 44(4):369-375.
26. Yang W., Gu C.C. A whole-genome simulator capable of modeling high-order epistasis for complex disease. Genet. Epidemiol. 2013, 37(7):686-694.
27. Zhu J., Sova P., Xu Q., et al. Stitching together multiple data dimensions reveals interacting metabolomic and transcriptomic networks that modulate cell regulation. PLoS Biol. 2012, 10(4):e1001301.